Physician-scientist-led careTrinidad & Tobago +

Meet the team

Clinical care,
grounded in science.

Founded by physician-scientist Dr. Farah Selina Mohammed, Genomika brings medical practice, molecular research and diagnostic expertise together in Trinidad and Tobago.

The expertise behind Genomika

From molecular insight
to patient care.

Dr. Mohammed’s work connects the science of disease with the clinical questions that matter to patients and their doctors.

Her background combines medicine with biochemistry, biology, infectious diseases and business administration, supported by scientific training in MALDI-TOF microbial identification, proteomics and CRISPR gene-editing technologies. Before entering clinical practice, she contributed to molecular-diagnostics research and university teaching at The University of the West Indies, with experience in PCR-based assay development, antimicrobial-resistance investigation and laboratory training.

She founded Genomika Health & Diagnostics Limited to make clinically appropriate genetic and molecular testing more accessible, and to help patients and referring clinicians understand how an investigation can inform care. That purpose is supported by both practical scientific experience and clinical training across major hospital specialties.

Academic foundation

Qualifications.

Formal study spanning clinical medicine, the biological sciences, infectious diseases and management.

MBBSBachelor of Medicine,
Bachelor of Surgery
The University of the West Indies
St. Augustine, Trinidad and Tobago
MScInfectious Diseases
London School of Hygiene & Tropical Medicine
United Kingdom
BScBiochemistry & Biology
Double major
The University of the West Indies
St. Augustine, Trinidad and Tobago
MBAMaster of Business Administration
Edinburgh Business School
Heriot-Watt University, United Kingdom
DiplomaModelling of Infectious Diseases
Institut Pasteur
Paris, France

Scientific and technical development

Training beyond
the degree.

Focused workshops, technical training and laboratory experience underpin her work in molecular science.

01

Public Health England & RCPath · London, UK

Microbiology,
MALDI-TOF & proteomics

MALDI-TOF mass-spectrometry training in microbial identification through Public Health England and the Royal College of Pathologists (RCPath), complemented by professional development in genomics and proteomics.

02

Gene-editing

CRISPR &
cell/gene technologies

Training in CRISPR experimental design and gene-edited animal models and cell lines, including knockout and knock-in approaches, single-cell cloning and clone confirmation.

Cell & gene therapies: her published academic work includes co-authorship of a BMJ editorial on CRISPR therapy for sickle cell disease.

View publication on PubMed
03

Workshop · J. Craig Venter Institute

Genomics, metagenomics
& bioinformatics

Advanced Genomics, Metagenomics and Bioinformatics workshop delivered by the J. Craig Venter Institute and hosted at UWI St. Augustine.

04

Technical training & experience

Next-generation sequencing

HiSeq next-generation sequencing training, with experience in FASTA/FASTQ sequence-data analysis and genomic data interpretation.

Experience that informs the work

Research. Teaching.
Clinical practice.

A background in developing methods, training others and applying scientific understanding in clinical settings.

Molecular research

Diagnostic methods
& antimicrobial resistance

At UWI, Dr. Mohammed contributed to research on the surveillance and molecular characterisation of antimicrobial resistance, including work with bacterial isolates and the development of conventional, multiplex and real-time PCR methods.

She also helped organise and deliver professional training in molecular approaches to antibiotic-resistance detection for healthcare and laboratory personnel.

University education

Medical microbiology
& molecular diagnosis

Her UWI teaching experience includes medical bacteriology, virology, parasitology and molecular diagnosis within Medical Biotechnology.

View historical UWI profile

She also contributed as a lecturer to a UWI workshop on bacterial antibiotic resistance and molecular detection methods, attended by more than 40 delegates from healthcare and laboratory institutions.

Read the UWI Today feature (2016)

National laboratory training

Supporting the
COVID-19 response

As part of a government-appointed task force in Trinidad and Tobago, she assisted in training Regional Health Authority laboratory teams in quantitative PCR and molecular techniques for SARS-CoV-2 testing.

This work included assay setup, validation and quality considerations.

Clinical foundation

Experience across
hospital specialties

Her clinical training at San Fernando General Hospital included Internal Medicine, Cardiology, General Surgery, Paediatric Surgery, Obstetrics & Gynaecology, and Paediatrics.

This experience informs Genomika’s emphasis on the clinical question, the patient’s history and the practical value of an investigation.

Portrait of Mr. Reinand Thompson

Laboratory leadership

Mr. Reinand Thompson

Head of Laboratory Services

View professional profile on LinkedIn

Molecular laboratory experience, scientific research and university training — supporting the development of Genomika’s molecular diagnostic services.

Reinand Thompson brings experience in molecular microbiology, genetic analysis and bioinformatics, supported by postgraduate training in advanced genomic and proteomic sciences. His background combines practical laboratory work at The University of the West Indies with research in infectious disease and cancer genetics.

His laboratory experience includes molecular analysis of microbial, human tissue and blood samples, with technical skills in DNA extraction, PCR, gel electrophoresis and molecular cloning. These capabilities inform his work alongside Dr. Farah Selina Mohammed in developing Genomika’s laboratory services.

COVID-19 laboratory response

He supported COVID-19 PCR testing with The University of the West Indies and the Trinidad Public Health Laboratory, contributing his laboratory skills to the national pandemic response.

View UWI’s record of his contribution

Molecular biology teaching & training

He previously lectured in cell and molecular biology and genetics at the College of Science, Technology and Applied Arts of Trinidad and Tobago (COSTAATT).

He has also participated in molecular biology teaching and practical laboratory training for students at UWI, sharing technical knowledge and supporting the development of laboratory skills.

International research presentations

He has presented research on antimicrobial resistance in Pseudomonas aeruginosa and Escherichia coli at international scientific conferences, including:

  • BSAC 2025

    British Society for Antimicrobial Chemotherapy

  • EPIDEMICS 10 2025

    Elsevier’s International Conference on Infectious Disease Dynamics

    San Diego, USA

  • ASM Microbe 2026

    American Society for Microbiology

    Washington, D.C., USA

Research with clinical relevance

His published work includes cancer genetic testing, the molecular biology of prostate cancer, and laboratory research on antimicrobial resistance and bacterial characterisation in Trinidad and Tobago.

Mini-review · 2024

Prostate-cancer molecular biology

First and corresponding author of a mini-review examining genetic and epigenetic changes in prostate cancer and their relevance to diagnosis and treatment resistance.

Read the review

Original research · 2025

Breast-cancer genetic testing

Co-author of a study evaluating DNA from preserved breast-cancer tissue for BRCA1 testing using PCR and Sanger sequencing.

Read the study on PubMed

Conference abstract · 2025

Antimicrobial-resistance research

First author of research combining susceptibility testing and PCR to investigate β-lactam resistance in Pseudomonas aeruginosa and Escherichia coli.

View the published abstract

Original research · 2022

Molecular microbiology

Co-author of research on Group B streptococcal colonisation in pregnancy, incorporating PCR-based identification and bacterial characterisation.

Read the study on PubMed

The company we are building

Local expertise.
A long-term commitment.

Genomika is a physician-scientist-led healthcare, clinical genomics and molecular diagnostics company. Our development plan brings together clinical assessment, appropriate testing and the progressive establishment of local molecular-diagnostic and next-generation sequencing capacity.

International reference laboratory arrangements form part of the initial pathway for selected investigations, subject to confirmation for each test.

For clinicians & laboratory partners

A conversation
grounded in expertise.

Contact Genomika to discuss clinical services, scientific collaboration or professional credential enquiries.

Contact Genomika

Website privacy

Your information.

The general enquiry form prepares an email in your own email application. Form entries are not submitted to a website database or stored in your browser by this site.

If you choose to send an email, the information is handled by your email provider and received by Genomika at the displayed email address. This form is intended for general enquiries only; please do not send medical records or sensitive health information through it.

This website does not add analytics or marketing cookies. The hosting service may process technical information needed to serve the site and manage access. Please contact Genomika to discuss an appropriate route for sharing clinical information.